Imaging in the diagnosis and treatment of non-small cell lung cancer

Respirology

Volumn 12, Issue 2, 2007, Pages 165-172

  Hicks, Rodney J ^a,c   Lau, Eddie ^a   Alam, Naveed Z ^a   Chen, Robert Y ^b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c NONE   (Australia)

Author keywords

Endoscopic ultrasound; Imaging; Lung cancer; PET; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ASPIRATION BIOPSY; BAYES THEOREM; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; INVASIVE PROCEDURE; LUNG NODULE; LUNG NON SMALL CELL CANCER; MEDIASTINUM LYMPH NODE; MINIMALLY INVASIVE SURGERY; NON INVASIVE MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSBRONCHIAL BIOPSY; TREATMENT PLANNING; ULTRASOUND;

BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; ENDOSONOGRAPHY; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MEDIASTINUM; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33846918840     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2006.01012.x     Document Type: Review

References (65)

1. Carney DN, Hansen HH. Non-small-cell lung cancer - stalemate or progress? N. Engl. J. Med. 2000; 343: 1261-2.
2. Feld R, Rubinstein LV, Weisenberger TH. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J. Clin. Oncol. 1984; 2: 1352-8.
3. Gould MK, Sanders GD, Barnett PG, Rydzak CE, Maclean CC, et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann. Intern. Med. 2003; 138: 724-35.
4. Dendukuri N, Rahme E, Belisle P, Joseph L. Bayesian sample size determination for prevalence and diagnostic test studies in the absence of a gold standard test. Biometrics 2004; 60: 388-97.
5. Mazzone PJ, Stoller JK. The pulmonologist's perspective regarding the solitary pulmonary nodule. Semin. Thorac. Cardiovasc. Surg. 2002; 14: 250-60.
6. Winer-Muram HT. The solitary pulmonary nodule. Radiology 2006; 239: 34-49.
7. Siegelman SS, Khouri NF, Leo FP, Fishman EK, Braverman RM, et al. Solitary pulmonary nodules: CT assessment. Radiology 1986; 160: 307-12.
8. Matsuoka S, Kurihara Y, Yagihashi K, Niimi H, Nakajima Y. Peripheral solitary pulmonary nodule: CT findings in patients with pulmonary emphysema. Radiology 2005; 235: 266-73.
9. Diederich S, Wormanns D, Heindel W. Lung cancer screening with low-dose CT. Eur. J. Radiol. 2003; 45: 2-7.
10. Tan BB, Flaherty KR, Kazerooni EA, Iannettoni MD. The solitary pulmonary nodule. Chest 2003; 123: 89S-96S.
11. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005; 237: 395-400.
12. Kostis WJ, Yankelevitz DF, Reeves AP, Fluture SC, Henschke CI. Small pulmonary nodules: reproducibility of three-dimensional volume tric measurement and estimation of time to follow-up CT. Radiology 2004; 231: 446-52.
13. Jeong YJ, Lee KS, Jeong SY, Chung MJ, Shim SS, et al. Solitary pulmonary nodule: characterization with combined wash-in and washout features at dynamic multi-detector row CT. Radiology 2005; 237: 675-83.
14. Schaefer JF, Vollmar J, Schick F, Vonthein R, Seemann MD, et al. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging - perfusion differences in malignant and benign lesions. Radiology 2004; 232: 544-53.
15. Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Momose M, et al. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. J. Nucl. Med. 2006; 47: 426-31.
16. Pitman AG, Hicks RJ, Binns DS, Ware RE, Kalff V, et al. Performance of sodium iodide based (18) F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses. Br. J. Radiol. 2002; 75: 114-21.
17. Keith CJ, Miles KA, Griffiths MR, Wong D, Pitman AG, et al. Solitary pulmonary nodules: accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data. Eur. J. Nucl. Med. Mol. Imaging 2002; 29: 1016-23.
18. Lejeune C, Al Zahouri K, Woronoff-Lemsi MC, Arveux P, Bernard A, et al. Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule. Eur. J. Health Econ. 2005; 6: 203-14.
19. Miles KA, Griffiths MR, Fuentes MA. Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules. Radiology 2001; 220: 548-53.
20. MacManus MP, Hicks RJ, Matthews JP, Hogg A, McKenzie AF, et al. High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy. Int. J. Radiat. Oncol. Biol. Phys 2001; 50: 287-93.
21. Eschmann SM, Friedel G, Paulsen F, Budach W, Harer-Mouline C, et al. FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radiochemotherapy. Eur. J. Nucl. Med. Mol. Imaging 2002; 29: 804-8.
22. MacManus MR, Hicks R, Fisher R, Rischin D, Michael M, et al. FDG-PET-detected extracranial metastasis in patients with non-small cell lung cancer undergoing staging for surgery or radical radiotherapy - survival correlates with metastatic disease burden. Acta Oncol. 2003; 42: 48-54.
23. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N. Engl. J. Med. 2003; 348: 2500-7.
24. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer. mediastinal staging in the 1990s - meta-analytic comparison of PET and CT. Radiology 1999; 213: 530-6.
25. Dunagan D, Chin R Jr, McCain T, Case L, Harkness B, et al. Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer. Chest 2001; 119: 333-9.
26. Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005; 236: 1011-19.
27. Pedersen BH, Vilmann P, Folke K, Jacobsen GK, Krasnik M, et al. Endoscopic ultrasonography and real-time guided fine-needle aspiration biopsy of solid lesions of the mediastinum suspected of malignancy. Chest 1996; 110: 539-44.
28. Pedersen BH, Vilmann P, Milman N, Folke K, Hancke S. Endoscopic ultrasonography with guided fine needle aspiration biopsy of a mediastinal mass lesion. Acta Radiol. 1995; 36: 326-8.
29. Vilmann P, Hancke S, Henriksen FW, Jacobsen GK. Endosonographically- guided fine needle aspiration biopsy of malignant lesions in the upper gastrointestinal tract. Endoscopy 1993; 25: 523-7.
30. Wegener M, Adamek RJ, Wedmann B. [Endosonographically directed transesophageal fine needle aspiration in diagnosis of mediastinal para-esophageal spaceoccupying processes]. Ultraschall. Med. 1992; 13: 289-91.
31. Wiersema MJ, Kochman ML, Chak A, Cramer HM, Kesler KA. Real-time endoscopic ultrasound-guided fine-needle aspiration of a mediastinal lymph node. Gastrointest. Endosc. 1993; 39: 429-31.
32. Eloubeidi MA, Seewald S, Tamhane A, Brand B, Chen VK, et al. EUS-guided FNA of the left adrenal gland in patients with thoracic or GI malignancies. Gastrointest. Endosc. 2004; 59: 627-33.
33. Jhala NC, Jhala D, Eloubeidi MA, Chhieng DC, Crowe DR, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy of the adrenal glands: analysis of 24 patients. Cancer 2004; 102: 308-14.
34. Eloubeidi MA, Cerfolio RJ, Chen VK, Desmond R, Syed S, et al. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans. Ann. Thorac. Surg. 2005; 79: 263-8.
35. Larsen SS, Krasnik M, Vilmann P, Jacobsen GK, Pedersen JH, et al. Endoscopic ultrasound guided biopsy of mediastinal lesions has a major impact on patient management. Thorax 2002; 57: 98-103.
36. Caddy G, Conron M, Wright G, Desmond P, Hart D, et al. The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC. Eur. Respir. J. 2005; 25: 410-15.
37. Arita T, Kuramitsu T, Kawamura M, Matsumoto T, Matsunaga N, et al. Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes. Thorax 1995; 50: 1267-9.
38. Wallace MB, Ravenel J, Block MI, Fraig M, Silvestri G, et al. Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography. Ann. Thorac. Surg. 2004; 77: 1763-8.
39. LeBlanc JK, Devereaux BM, Imperiale TF, Kesler K, DeWitt JM, et al. Endoscopic ultrasound in non-small cell lung cancer and negative mediastinum on computed tomography. Am. J. Respir. Crit. Care Med. 2005; 171: 177-82.
40. Wallace MB, Block M, Hoffman BJ, Hawes RH, Silvestri G, et al. Detection of telomerase expression in mediastinal lymph nodes of patients with lung Cancer. Am. J. Respir. Crit. Care Med. 2003; 167: 1670-5.
41. Toloza EM, Harpole L, Detterbeck F, McCrory DC. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123: 157S-166S.
42. Fritscher-Ravens A, Sriram PV, Topalidis T, Hauber HP, Meyer A, et al. Diagnosing sarcoidosis using endosonography-guided fine-needle aspiration. Chest 2000; 118: 928-35.
43. Annema JT, Veselic M, Rabe KF. Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of sarcoidosis. Eur. Respir. J. 2005; 25: 405-9.
44. Hurter T, Hanrath P. Endobronchial sonography: feasibility and preliminary results. Thorax 1992; 47: 565-7.
45. Herth FJ, Ernst A, Eberhardt R, Vilmann P, Dienemann H, et al. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum. Eur. Respir. J. 2006 (Epub ahead of print).
46. Riquet M, Manac'h D, Le Pimpec Barthes F, Dujon A, Debrosse D, et al. Prognostic value of T and N in non small cell lung cancer three centimeters or less in diameter. Eur. J. Cardiothorac. Surg. 1997; 11: 440-3.
47. Paone G, Nicastri E, Lucantoni G, Dello Iacono R, Battistoni P, et al. Endobronchial ultrasound-driven biopsy in the diagnosis of peripheral lung lesions. Chest 2005; 128: 3551-7.
48. Asahina H, Yamazaki K, Onodera Y, Kikuchi E, Shinagawa N, et al. Transbronchial biopsy using endobronchial ultrasonography with a guide sheath and virtual bronchoscopic navigation. Chest 2005; 128: 1761-5.
49. Varadarajulu S, Hoffman BJ, Hawes RH, Eloubeidi MA. EUS-guided FNA of lung masses adjacent to or abutting the esophagus after unrevealing CT-guided biopsy or bronchoscopy. Gastrointest. Endosc. 2004; 60: 293-7.
50. Kalff V, Hicks RJ, MacManus MP, Binns DS, McKenzie AF, et al. Clinical impact of (18) F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. J. Clin. Oncol. 2001; 19: 111-18.
51. van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002; 359: 1388-93.
52. Verboom P, van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, et al. Cost-effectiveness of FDGPET in staging non-small cell lung cancer: the PLUS study. Eur. J. Nucl. Med. Mol. Imaging 2003; 30: 1444-9.
53. Viney RC, Boyer MJ, King MT, Kenny PM, Pollicino CA, et al. Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung Cancer. J. Clin. Oncol. 2004; 22: 2357-62.
54. Hicks RJ, Kalff V, MacManus MP, Ware RE, Hogg A, et al. (18) F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J. Nucl. Med. 2001; 42: 1596-604.
55. MacManus MP, Wong K, Hicks RJ, Matthews JP, Wirth A, et al. Early mortality after radical radiotherapy for non-small-cell lung cancer. comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center. Int. J. Radiat. Oncol. Biol. Phys. 2002; 52: 351-61.
56. Ciernik IF, Dizendorf E, Baumert BG, Reiner B, Burger C, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int. J. Radiat. Oncol. Biol. Phys. 2003; 57: 853-63.
57. Fritscher-Ravens A, Soehendra N, Schirrow L, Sriram PV, Meyer A, et al. Role of transesophageal endosonography-guided fine-needle aspiration in the diagnosis of lung cancer. Chest 2000; 117: 339-45.
58. Gress FG, Savides TJ, Sandler A, Kesler K, Conces D, et al. Endoscopic ultrasonography, fine-needle aspiration biopsy guided by endoscopic ultrasonography, and computed tomography in the preoperative staging of non-small-cell lung cancer: a comparison study. Ann. Intern. Med. 1997; 127: 604-12.
59. Catalano MF, Rosenblatt ML, Chak A, Sivak MV Jr, Scheiman J, et al. Endoscopic ultrasound-guided fine needle aspiration in the diagnosis of mediastinal masses of unknown origin. Am. J. Gastroenterol. 2002; 97: 2559-65.
60. Chong AK, Caddy GR, Desmond PV, Chen RY. Prospective study of the clinical impact of EUS. Gastrointest. Endosc. 2005; 62: 399-405.
61. Kramer H, van Putten JW, Post WJ, van Dullemen HM, Bongaerts AH, et al. Oesophageal endoscopic ultrasound with fine needle aspiration improves and simplifies the staging of lung cancer. Thorax 2004; 59: 596-601.
62. Wallace MB, Silvestri GA, Sahai AV, Hawes RH, Hoffman BJ, et al. Endoscopic ultrasound-guided fine needle aspiration for staging patients with carcinoma of the lung. Ann. Thorac. Surg. 2001; 72: 1861-7.
63. Harewood GC, Wiersema MJ, Edell ES, Liebow M. Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy. Mayo Clin. Proc. 2002; 77: 155-64.
64. Eloubeidi MA, Tamhane A, Chen VK, Cerfolio RJ. Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy. Ann. Thorac. Surg. 2005; 80: 1231-9.
65. Aabakken L, Silvestri GA, Hawes R, Reed CE, Marsi V, et al. Cost-efficacy of endoscopic ultrasonography with fine-needle aspiration vs. mediastinotomy in patients with lung cancer and suspected mediastinal adenopathy. Endoscopy 1999; 31: 707-11.